Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
4,575.00
+105.00 (2.35%)
At close: Feb 6, 2026
-42.74% (1Y)
| Market Cap | 226.69B -40.1% |
| Revenue (ttm) | 66.40B -23.9% |
| Net Income | -28.37B |
| EPS | -566.79 |
| Shares Out | 49.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 376,396 |
| Average Volume | 1,003,895 |
| Open | 4,385.00 |
| Previous Close | 4,470.00 |
| Day's Range | 4,290.00 - 4,650.00 |
| 52-Week Range | 3,685.00 - 9,520.00 |
| Beta | -0.64 |
| RSI | 49.52 |
| Earnings Date | Mar 20, 2026 |